Scs Capital Management LLC Astrazeneca PLC Transaction History
Scs Capital Management LLC
- $9.12 Billion
- Q3 2025
A detailed history of Scs Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Scs Capital Management LLC holds 183,607 shares of AZN stock, worth $16.4 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
183,607
Previous 184,048
0.24%
Holding current value
$16.4 Million
Previous $12.9 Million
9.52%
% of portfolio
0.15%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,541Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...